JPRN-UMIN000014570招募中4 期
Comparison of usefulness between denosumab and alendronate after teriparatide therapy in patients with glucocorticoid-induced osteoporosis (GIOP) - Denosumab or alendronate after teriparatide in GIOP patients
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who have serious renal disorder (eGFR<35ml/min or Cr>1.5mg/ml) 2)Patient who has a history of renal stone past 5 years 3)Patients with primary or secondary hyperparathyroidism 4)Patients with hyperthyroidism or hypothyroidism 5)Patients who are considered to be contraindicated for bisphosphonates or denosumab 6)Patients who are treated with warfarin or digitalis 7)Patients who have newly received drugs having influence on bone remodeling within 6 months at inclusion of the study (estriol, estradiol, Vitamin D3, Vitamin K2, SERM(Raloxifene, bazedoxifene), Calcitonin, Ipriflavone, Steroids) 8)Patients who had received bisphosphonates during teriparatide therapy 9) Patients who are thought to be inappropriate for this study by physician
研究者
相似试验
招募中
不适用
Comparison of therapeutic effects of denosumab and romosozumab using Propensity Score Matching in postmenopausal osteoporosis patientsPrimary osteoprosisosteoprosisD0 1 0 0 2 4JPRN-jRCT1041200090Kobayakawa Tomonori150
招募中
不适用
The effects of denosumab compared with alendronate on glucocorticoid-induced osteoporosis in patients with malignant lymphomaglucocorticoid-induced osteoporosis in patients with malignant lymphomaJPRN-UMIN000038881Toyama University Hospital Department of Hematology100
已完成
3 期
A randomised, double-blind, placebo controlled trial to examine the effects of total oestradiol depletion on bone microstructure and the efficacy of denosumab in preventing microstructural bone decay in premenopausal women with early breast cancerMetabolic and Endocrine - Other endocrine disordersCancer - BreastMusculoskeletal - Osteoporosisbreast cancerpremenopausal osteoporosisACTRN12616001051437Professor Mathis Grossmann74
招募中
不适用
Denosumab and Alendronate, Examination of the effective of Glucocorticoid-induced OsteoporosisSteroid induced osteoporosisJPRN-UMIN000033122The First Department of Internal Medicine University of Occupational and Environmental Health, Japan, School of Medicine200
已完成
不适用
The effects of denosumab compared with oral bisphosphonates (BP) in patients with RA complicated with osteoporosis on the progression of structural damage, BMD and disease activity.rheumatoid arthritisJPRN-UMIN000014737Yokohama City University Medical Center286